Perceptions, knowledge and adoption of artificial intelligence in rheumatology: results from a British Society for Rheumatology survey
Clicks: 4
ID: 325450
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
4 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #148 of 206 articles by views in Lara D. Veeken
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 206 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Objectives Artificial intelligence (AI) and machine learning applications are rapidly expanding across healthcare. Successful implementation of AI technologies in rheumatology will depend not only on technical performance but also on the perceptions and preparedness of end-users. This study evaluated the current opinions, expectations, and concerns of AI among healthcare professionals and researchers in rheumatology across the UK. Methods A 19-item survey was designed and distributed through national and regional networks aimed at the rheumatology workforce between June 2025 - January 2026, targeted at consultant rheumatologists, doctors-in-training, allied health professionals, specialist nurses, and non-clinical researchers in rheumatology. The questions included respondent background data, current applications of AI in clinical care and research, opinions about AI in terms of perceived impact, concerns, educational needs and expected performance. Results Of the 218 respondents, 39% to 40% reported daily or weekly use of AI in research and clinical practice respectively. The most common clinical uses were using LLMs to look up medical facts (45%), to improve grammar/spelling of clinical documentation (28%), generate differential diagnoses (22%) and use of ambient scribes (17%). 86% anticipated that AI would substantially impact clinical practice in five years or less. Administrative tasks (85%) and musculoskeletal imaging (63%) were perceived as the areas likely to experience the greatest impact from AI. Highlighted concerns included data security/privacy (70%), medical liability (70%), followed by lack of explainability (47%). One in four reported excellent confidence in using digital technology, with only 6% self-rating their AI knowledge as excellent. A strong interest in education about AI was expressed regarding several areas including the ethical and safe use of AI (66%), safe and efficient use of LLMs in clinical practice (64%), and ambient AI scribes (59%). Conclusions AI is already being used frequently in UK rheumatology practice and research, with most anticipating a considerable impact on clinical care within the next five years or less. However, despite enthusiasm for adoption, important concerns regarding data security, liability, and explainability remain, alongside low self-reported AI knowledge, highlighting the need for targeted education, robust governance, and safe clinical implementation strategies.
| Reference Key |
openalex_W7172075447
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hansel Canagarajah, Pratyasha Saha, Jordan Tsigarides, Nicholas Fuggle, Meghna; id_orcid 0000-0002-1487-277X Jani |
| Journal | Lara D. Veeken |
| Year | 2026 |
| DOI |
10.1093/rheumatology/keag454
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.